Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Chest 130 , 15111519 (2006)
Triple agonism at GIP, GLP-1 and glucagon receptors in a single molecule Body-weight and energy-balance endpoints (rapidly expanding 20252026 research literature) Glucagon-receptor engagement that sets it apart from single- and dual-agonist compounds Benchmarked against Semaglutide and Tirzepatide in comparative research Areas of laboratory and preclinical research only
Hobson, B
Excess fat deposited in visceral adipose tissue and ectopic depots (such as muscle and liver) has also been related to increased cardiometabolic risk, as has a greater fat-to-lean mass proportion (e.g., normal-weight metabolically obese) [3]
US$ 20.63
US$ 22.28
US$ 23.47
US$ 25.69
US$ 25.79
